Xenon Pharmaceuticals Pre-Tax Profit Margin 2012-2026 | XENE

Current and historical pre-tax profit margin for Xenon Pharmaceuticals (XENE) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Xenon Pharmaceuticals pre-tax profit margin for the three months ending June 30, 2026 was .
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Xenon Pharmaceuticals Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2022-09-30 $0.01B $-0.11B -814.29%
2022-06-30 $0.02B $-0.09B -418.18%
2022-03-31 $0.02B $-0.08B -360.87%
2021-12-31 $0.02B $-0.08B -438.89%
2021-09-30 $0.02B $-0.07B -347.37%
2021-06-30 $0.02B $-0.06B -327.78%
2021-03-31 $0.03B $-0.04B -127.59%
2020-12-31 $0.03B $-0.03B -87.50%
2020-09-30 $0.03B $-0.03B -90.00%
2020-06-30 $0.03B $-0.03B -100.00%
2017-12-31 $0.00B $-0.03B 0.00%
2017-09-30 $0.00B $-0.03B 0.00%
2017-06-30 $0.00B $-0.03B 0.00%
2017-03-31 $0.00B $-0.03B 0.00%
2016-12-31 $0.00B $-0.02B -2300.00%
2016-09-30 $0.00B $-0.02B -525.00%
2016-06-30 $0.01B $-0.02B -212.50%
2016-03-31 $0.01B $-0.01B -83.33%
2015-12-31 $0.02B $-0.02B -106.67%
2015-09-30 $0.02B $-0.01B -64.71%
2015-06-30 $0.03B $0.00B 7.69%
2015-03-31 $0.03B $0.00B 7.41%
2014-12-31 $0.03B $0.01B 42.86%
2014-06-30 $0.02B $0.01B 38.10%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.440B $0.008B
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $251.014B 16.67
Amgen (AMGN) United States $203.088B 16.79
Gilead Sciences (GILD) United States $181.405B 0.00
Vertex Pharmaceuticals (VRTX) United States $130.616B 30.24
Bristol Myers Squibb (BMY) United States $130.182B 9.79
GSK (GSK) United Kingdom $101.156B 10.51
Regeneron Pharmaceuticals (REGN) United States $79.698B 19.87
Argenex SE (ARGX) Netherlands $61.295B 37.62
CSL (CSLLY) Australia $60.765B 0.00
Moderna (MRNA) United States $57.398B 0.00
Revolution Medicines (RVMD) United States $43.909B 0.00
Royalty Pharma (RPRX) United States $33.620B 11.14
Illumina (ILMN) United States $33.566B 43.16
Biogen (BIIB) United States $31.940B 15.47
Alnylam Pharmaceuticals (ALNY) United States $31.883B 44.29
Roivant Sciences (ROIV) United Kingdom $28.532B 0.00
Insmed (INSM) United States $26.188B 0.00
Incyte (INCY) United States $24.676B 15.33
BioNTech SE (BNTX) Germany $24.451B 0.00
Guardant Health (GH) United States $23.572B 0.00
Genmab (GMAB) Denmark $21.302B 24.57
Genmab (GNMSF) Denmark $20.871B 24.26
Exact Sciences (EXAS) United States $19.699B 2581.00
Swedish Orphan Biovitrum (BIOVF) Sweden $17.133B 22.81
Jazz Pharmaceuticals (JAZZ) Ireland $15.633B 10.43
Ascendis Pharma (ASND) Denmark $14.956B 133.21
Exelixis (EXEL) United States $14.099B 18.01
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $13.133B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.476B 38.36
Halozyme Therapeutics (HALO) United States $12.059B 21.55
Bio-Techne Corp (TECH) United States $11.344B 42.06
Axsome Therapeutics (AXSM) United States $10.689B 0.00
Krystal Biotech (KRYS) United States $9.965B 42.19
Arrowhead Pharmaceuticals (ARWR) United States $9.954B 0.00
Repligen (RGEN) United States $9.861B 88.69
Nuvalent (NUVL) United States $9.793B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.762B 39.34
Kymera Therapeutics (KYMR) United States $9.408B 0.00
Abivax SA (ABVX) France $9.306B 0.00
Protagonist Therapeutics (PTGX) United States $9.279B 139.22
Vaxcyte (PCVX) United States $8.811B 0.00
QIAGEN (QGEN) Netherlands $8.754B 17.54
Praxis Precision Medicines (PRAX) United States $8.736B 0.00
Twist Bioscience (TWST) United States $8.660B 0.00
ImmunityBio (IBRX) United States $8.627B 0.00
Cytokinetics (CYTK) United States $8.624B 0.00
Apogee Therapeutics (APGE) United States $8.402B 0.00
TG Therapeutics (TGTX) United States $8.119B 19.01
Spyre Therapeutics (SYRE) United States $7.998B 0.00
Alkermes (ALKS) Ireland $7.722B 107.05
Immunovant (IMVT) United States $7.570B 0.00
Cidara Therapeutics (CDTX) United States $6.960B 0.00
Merus (MRUS) Netherlands $6.826B 0.00
Belite Bio (BLTE) United States $6.824B 0.00
Arcellx (ACLX) United States $6.715B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.632B 0.00
CG Oncology (CGON) United States $6.431B 0.00
Mirum Pharmaceuticals (MIRM) United States $6.097B 0.00
Scholar Rock Holding (SRRK) United States $6.089B 0.00
Terns Pharmaceuticals (TERN) United States $6.074B 0.00
Travere Therapeutics (TVTX) United States $5.892B 0.00
Liquidia (LQDA) United States $5.883B 47.97
Kiniksa Pharmaceuticals (KNSA) United Kingdom $5.864B 77.47
Dianthus Therapeutics (DNTH) United States $5.727B 0.00
Erasca (ERAS) United States $5.684B 0.00
Cogent Biosciences (COGT) United States $5.681B 0.00
Ligand Pharmaceuticals (LGND) United States $5.522B 29.62
PTC Therapeutics (PTCT) United States $5.479B 0.00
Apellis Pharmaceuticals (APLS) United States $5.214B 313.77
CRISPR Therapeutics AG (CRSP) Switzerland $5.012B 0.00
Edgewise Therapeutics (EWTX) United States $4.738B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.611B 43.16
Amicus Therapeutics (FOLD) United States $4.540B 482.00
Akero Therapeutics (AKRO) United States $4.499B 0.00
Parabilis Medicines (PBLS) United States $4.413B 0.00
Telix Pharmaceuticals (TLX) Australia $4.359B 0.00
Veradermics (MANE) United States $4.341B 0.00
Adaptive Biotechnologies (ADPT) United States $4.258B 0.00
Iovance Biotherapeutics (IOVA) United States $4.240B 0.00
Celcuity (CELC) United States $4.047B 0.00
Tango Therapeutics (TNGX) United States $4.028B 0.00
AbCellera Biologics (ABCL) Canada $3.498B 0.00
Viking Therapeutics (VKTX) United States $3.494B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.433B 0.00
Legend Biotech (LEGN) United States $3.424B 0.00
GRAIL (GRAL) United States $3.390B 0.00
IDEAYA Biosciences (IDYA) United States $3.309B 0.00
Denali Therapeutics (DNLI) United States $3.258B 0.00
Arcus Biosciences (RCUS) United States $3.097B 0.00
Zealand Pharma (ZLDPF) Denmark $3.076B 7.13
Celldex Therapeutics (CLDX) United States $3.024B 0.00
UniQure (QURE) Netherlands $2.990B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.955B 111.95
MBX Biosciences (MBX) United States $2.942B 0.00
Zai Lab (ZLAB) China $2.822B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $2.769B 0.00
AtaiBeckley Inc (ATAI) Netherlands $2.726B 0.00
Immunome (IMNM) United States $2.720B 0.00
Structure Therapeutics (GPCR) United States $2.712B 0.00
Disc Medicine (IRON) United States $2.584B 0.00
Nurix Therapeutics (NRIX) United States $2.577B 0.00
Mineralys Therapeutics (MLYS) United States $2.556B 0.00
Precigen (PGEN) United States $2.496B 0.00
Pharvaris (PHVS) Netherlands $2.489B 0.00
Bavarian Nordic (BVNRY) Denmark $2.482B 10.55
Viridian Therapeutics (VRDN) United States $2.473B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.456B 13.69
NeoGenomics (NEO) United States $2.427B 0.00
Vera Therapeutics (VERA) United States $2.426B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.406B 0.00
Braveheart Bio (BRVE) United States $2.405B 0.00
Beam Therapeutics (BEAM) United States $2.398B 0.00
SELLAS Life Sciences (SLS) United States $2.280B 0.00
Day One Biopharmaceuticals (DAWN) United States $2.218B 0.00
Sarepta Therapeutics (SRPT) United States $2.189B 0.00
Palvella Therapeutics (PVLA) United States $2.179B 0.00
Trevi Therapeutics (TRVI) United States $2.143B 0.00
Zenas BioPharma (ZBIO) United States $2.081B 0.00
Generate Biomedicines (GENB) United States $2.078B 0.00
Kodiak Sciences (KOD) United States $2.073B 0.00
Rapport Therapeutics (RAPP) United States $2.048B 0.00
Urogen Pharma (URGN) United States $2.040B 0.00
Nuvation Bio (NUVB) United States $2.037B 0.00
Vericel (VCEL) United States $2.034B 84.51
Alamar Biosciences (ALMR) United States $1.995B 0.00
Agios Pharmaceuticals (AGIO) United States $1.959B 0.00
ADMA Biologics Inc (ADMA) United States $1.929B 12.13
Mesoblast (MESO) Australia $1.914B 0.00
GH Research (GHRS) Ireland $1.890B 0.00
NovoCure (NVCR) Jersey $1.881B 0.00
Fortrea Holdings (FTRE) United States $1.876B 32.88
Hemab Therapeutics Holdings (COAG) United States $1.874B 0.00
Galapagos (GLPG) Belgium $1.871B 0.00
Biohaven (BHVN) United States $1.864B 0.00
Zymeworks (ZYME) United States $1.848B 0.00
Lakefront Biotherapeutics - (LKFT) Belgium $1.840B 0.00
Dynavax Technologies (DVAX) United States $1.819B 53.41
Stoke Therapeutics (STOK) United States $1.816B 0.00
Septerna (SEPN) United States $1.814B 0.00
Nanobiotix S.A - (NBTX) France $1.785B 0.00
Vir Biotechnology (VIR) United States $1.767B 0.00
Kailera Therapeutics (KLRA) United States $1.744B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.735B 0.00
Pharma Mar (PHMMF) Spain $1.703B 0.00
ANI Pharmaceuticals (ANIP) United States $1.656B 10.13
Immunocore Holdings (IMCR) United Kingdom $1.636B 0.00
Forte Biosciences (FBRX) United States $1.634B 0.00
AnaptysBio (ANAB) United States $1.619B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.603B 0.00
Rapt Therapeutics (RAPT) United States $1.599B 0.00
Intellia Therapeutics (NTLA) United States $1.592B 0.00
Eton Pharmaceuticals (ETON) United States $1.570B 144.55
Inhibrx Biosciences (INBX) United States $1.554B 0.00
Galecto (DMRA) Denmark $1.528B 0.00
Latigo Biotherapeutics Inc (LTGO) United States $1.526B 0.00
Novavax (NVAX) United States $1.522B 0.00
Avalyn Pharma (AVLN) United States $1.520B 0.00
Tyra Biosciences (TYRA) United States $1.518B 0.00
Alvotech (ALVO) Luxembourg $1.515B 0.00
Bicara Therapeutics (BCAX) United States $1.500B 0.00
Ascentage Pharma Group - (AAPG) China $1.494B 0.00
Mind Medicine (MindMed) (MNMD) United States $1.480B 0.00
LB Pharmaceuticals Inc (LBRX) United States $1.388B 0.00
ArriVent BioPharma (AVBP) United States $1.379B 0.00
First Tracks Biotherapeutics (TRAX) United States $1.375B 0.00
Absci (ABSI) United States $1.363B 0.00
Maze Therapeutics (MAZE) United States $1.346B 0.00
Cullinan Therapeutics (CGEM) United States $1.322B 0.00
Vor Biopharma (VOR) $1.321B 0.00
Ultragenyx Pharmaceutical (RARE) United States $1.289B 0.00
Certara (CERT) United States $1.281B 35.00
Oric Pharmaceuticals (ORIC) United States $1.281B 0.00
MeiraGTx Holdings (MGTX) United States $1.226B 17.97
Replimune (REPL) United States $1.222B 0.00
Alto Neuroscience (ANRO) United States $1.187B 0.00
Immatics (IMTX) Germany $1.176B 0.00
MannKind (MNKD) United States $1.145B 0.00
Monte Rosa Therapeutics (GLUE) United States $1.108B 0.00
Jade Biosciences (JBIO) United States $1.105B 0.00
Corvus Pharmaceuticals (CRVS) United States $1.089B 0.00
Alumis (ALMS) United States $1.087B 0.00
Castle Biosciences (CSTL) United States $1.085B 0.00
Attovia Therapeutics (ATTO) United States $1.082B 0.00
SL SCIENCE HLDG (SLBT) $1.071B 0.00
Odyssey Therapeutics (ODTX) United States $1.057B 0.00
Obsidian Therapeutics (OBX) United States $1.050B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $1.038B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $1.019B 0.00
Kura Oncology (KURA) United States $1.005B 0.00
Janux Therapeutics (JANX) United States $1.005B 0.00
Ventyx Biosciences (VTYX) United States $1.003B 0.00
Arbutus Biopharma (ABUS) United States $1.002B 6.41
SpyGlass Pharma (SGP) United States $0.968B 0.00
Adlai Nortye (ANL) Cayman Islands $0.966B 0.00
Pacira BioSciences (PCRX) United States $0.960B 15.44
Sana Biotechnology (SANA) United States $0.946B 0.00
CureVac (CVAC) Germany $0.927B 0.00
Faeth Therapeutics (FTH) United States $0.914B 0.00
Solid Biosciences (SLDB) United States $0.897B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.894B 0.00
WAVE Life Sciences (WVE) Singapore $0.879B 0.00
Immix Biopharma (IMMX) United States $0.868B 0.00
Olema Pharmaceuticals (OLMA) United States $0.856B 0.00
Candel Therapeutics (CADL) United States $0.851B 0.00
Geron (GERN) United States $0.842B 0.00
Inventiva S.A (IVA) France $0.802B 0.00
Climb Bio (CLYM) United States $0.799B 0.00
Anbio Biotechnology (NNNN) Germany $0.793B 0.00
Design Therapeutics (DSGN) United States $0.765B 0.00
Pharming Group (PHAR) Netherlands $0.747B 87.92
Gyre Therapeutics (GYRE) United States $0.746B 0.00
Annexon (ANNX) United States $0.743B 0.00
Pharming Group (PHGUF) Netherlands $0.742B 92.08
DBV Technologies S.A (DBVT) France $0.739B 0.00
Astria Therapeutics (ATXS) United States $0.718B 0.00
Aura Biosciences (AURA) United States $0.718B 0.00
Nuvectis Pharma (NVCT) United States $0.716B 0.00
Monopar Therapeutics (MNPR) United States $0.700B 0.00
Crescent Biopharma (CBIO) United States $0.698B 0.00
MiMedx (MDXG) United States $0.688B 24.84
BlossomHill Therapeutics (BLSM) United States $0.679B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.676B 0.00
Neurogene (NGNE) United States $0.674B 0.00
Verastem (VSTM) United States $0.665B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.660B 0.00
Sagimet Biosciences (SGMT) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Cytek Biosciences (CTKB) United States $0.636B 0.00
Starling Oncology (STLN) United States $0.630B 0.00
CorMedix Inc (CRMD) United States $0.605B 4.08
Scribe Therapeutics (SCTX) $0.599B 0.00
Shattuck Labs (STTK) United States $0.599B 0.00
Allogene Therapeutics (ALLO) United States $0.594B 0.00
CytomX Therapeutics (CTMX) United States $0.586B 0.00
Bright Minds Biosciences (DRUG) United States $0.586B 0.00
Oculis Holding AG (OCS) Switzerland $0.584B 0.00
Prime Medicine (PRME) United States $0.570B 0.00
MapLight Therapeutics (MPLT) United States $0.560B 0.00
Tectonic Therapeutic (TECX) United States $0.557B 0.00
Arvinas (ARVN) United States $0.533B 82.60
Ovid Therapeutics (OVID) United States $0.529B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.527B 0.00
REGENXBIO (RGNX) United States $0.524B 0.00
Contineum Therapeutics (CTNM) United States $0.520B 0.00
Eikon Therapeutics (EIKN) United States $0.514B 0.00
XOMA Royalty (XOMA) United States $0.504B 95.64
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
Entera Bio (ENTX) Israel $0.497B 0.00
Opus Genetics (IRD) United States $0.481B 0.00
Puma Biotechnology (PBYI) United States $0.477B 17.79
Zura Bio (ZURA) United States $0.472B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.471B 0.00
Kamada (KMDA) Israel $0.465B 21.29
Arcturus Therapeutics Holdings (ARCT) United States $0.450B 0.00
Vogenx Inc (VOGX) United States $0.448B 0.00
AgomAb Therapeutics (AGMB) Belgium $0.441B 0.00
Cabaletta Bio (CABA) United States $0.440B 0.00
Prothena (PRTA) Ireland $0.436B 0.00
Artiva Biotherapeutics (ARTV) United States $0.436B 0.00
Kyverna Therapeutics (KYTX) United States $0.430B 0.00
C4 Therapeutics (CCCC) United States $0.422B 0.00
Atea Pharmaceuticals (AVIR) United States $0.419B 0.00
PureTech Health (PRTCY) United States $0.418B 0.00
Editas Medicine (EDIT) United States $0.404B 0.00
PureTech Health (PRTC) United States $0.402B 0.00
Turn Therapeutics (TTRX) United States $0.401B 0.00
Rezolute (RZLT) United States $0.400B 0.00
GENFIT S.A (GNFTY) France $0.391B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.391B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.389B 0.00
Benitec Biopharma (BNTC) United States $0.385B 0.00
BioAge Labs (BIOA) United States $0.375B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.374B 0.00
Adherex Technologies (FENC) United States $0.373B 0.00
Myriad Genetics (MYGN) United States $0.371B 0.00
Alpha Teknova (TKNO) United States $0.370B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.363B 0.00
Evommune (EVMN) United States $0.363B 0.00
X4 Pharmaceuticals (XFOR) United States $0.359B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.358B 0.00
DiaMedica Therapeutics (DMAC) United States $0.352B 0.00
Palisade Bio (PALI) United States $0.351B 0.00
Ocugen (OCGN) United States $0.337B 0.00
Compass Therapeutics (CMPX) United States $0.333B 0.00
Q32 Bio (QTTB) United States $0.333B 5.40
Emergent Biosolutions (EBS) United States $0.326B 4.42
Agenus (AGEN) United States $0.323B 2.04
EyePoint (EYPT) United States $0.316B 0.00
Abeona Therapeutics (ABEO) United States $0.313B 0.00
Sionna Therapeutics (SION) United States $0.311B 0.00
SAB Biotherapeutics (SABS) United States $0.310B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.302B 0.00
Upstream Bio (UPB) United States $0.300B 0.00
InflaRx (IFRX) Germany $0.298B 0.00
Northwest Biotherapeutics (NWBO) United States $0.298B 0.00
Amarin (AMRN) Ireland $0.294B 0.00
Fulcrum Therapeutics (FULC) United States $0.288B 0.00
Immuneering (IMRX) United States $0.287B 0.00
Fate Therapeutics (FATE) United States $0.282B 0.00
Anika Therapeutics (ANIK) United States $0.280B 1045.50
YD Bio (YDES) $0.280B 0.00
Sutro Biopharma (STRO) United States $0.275B 0.00
AC Immune (ACIU) Switzerland $0.273B 0.00
Entrada Therapeutics (TRDA) United States $0.268B 0.00
CAMP4 Therapeutics (CAMP) United States $0.263B 0.00
ALX Oncology Holdings (ALXO) United States $0.261B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.245B 0.00
Invivyd (IVVD) United States $0.245B 0.00
Starpharma Holdings (SPHRY) Australia $0.241B 0.00
Adocia (ADOCY) France $0.239B 0.00
Niagen Bioscience (NAGE) United States $0.239B 18.75
Cartesian Therapeutics (RNAC) United States $0.239B 0.00
Greenwich LifeSciences (GLSI) United States $0.236B 0.00
Whitehawk Therapeutics (WHWK) United States $0.233B 0.00
Cue Biopharma (CUE) United States $0.230B 0.00
Compugen (CGEN) Israel $0.228B 6.34
Alector (ALEC) United States $0.227B 0.00
Anavex Life Sciences (AVXL) United States $0.226B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.224B 0.00
Keros Therapeutics (KROS) United States $0.221B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.220B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.209B 0.00
Innate Pharma S.A (IPHA) France $0.208B 0.00
Nkarta (NKTX) United States $0.206B 0.00
Coherus Oncology (CHRS) United States $0.205B 0.00
AN2 Therapeutics (ANTX) United States $0.202B 0.00
PepGen (PEPG) United States $0.200B 0.00
Satellos Bioscience (MSLE) Canada $0.199B 0.00
Adagene (ADAG) China $0.196B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.194B 0.00
Alpha Cognition (ACOG) Canada $0.192B 0.00
Voyager Therapeutics (VYGR) United States $0.190B 0.00
NovaBridge Biosciences (NBP) United States $0.184B 0.00
Precision BioSciences (DTIL) United States $0.182B 0.00
NervGen Pharma (NGEN) Canada $0.173B 0.00
Molecular Partners AG (MOLN) Switzerland $0.170B 0.00
Tharimmune (THAR) United States $0.169B 0.00
Outlook Therapeutics (OTLK) United States $0.164B 0.00
Cellectis S.A (CLLS) France $0.162B 0.00
Jyong Biotech (MENS) Taiwan $0.161B 0.00
Spruce Biosciences (SPRB) United States $0.159B 0.00
Lifecore Biomedical (LFCR) United States $0.157B 0.00
Neumora Therapeutics (NMRA) United States $0.156B 0.00
Codexis (CDXS) United States $0.153B 0.00
Humacyte (HUMA) United States $0.153B 0.00
Tenaya Therapeutics (TNYA) United States $0.150B 0.00
Mersana Therapeutics (MRSN) United States $0.145B 0.00
Immunic (IMUX) United States $0.141B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.139B 0.00
Caribou Biosciences (CRBU) United States $0.136B 0.00
Novogen (KZIA) Australia $0.134B 0.00
LENZ Therapeutics (LENZ) United States $0.133B 0.00
Biomea Fusion (BMEA) United States $0.130B 0.00
Equillium (EQ) United States $0.130B 0.00
TuHURA Biosciences (HURA) United States $0.129B 0.00
EnGene Therapeutics Inc (ENGN) Canada $0.127B 0.00
Conexeu Sciences (CNXU) United States $0.126B 0.00
MaxCyte (MXCT) United States $0.123B 0.00
VTv Therapeutics (VTVT) United States $0.120B 0.00
Inovio Pharmaceuticals (INO) United States $0.120B 0.00
OnKure Therapeutics (OKUR) United States $0.118B 0.00
Promis Neurosciences (PMN) Canada $0.116B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.116B 0.00
Rani Therapeutics Holdings (RANI) United States $0.115B 0.00
Repare Therapeutics (RPTX) Canada $0.114B 0.00
Nautilus Biotechnology (NAUT) United States $0.113B 0.00
Black Diamond Therapeutics (BDTX) United States $0.113B 0.00
Genelux (GNLX) United States $0.112B 0.00
Aardvark Therapeutics (AARD) United States $0.110B 0.00
Coya Therapeutics (COYA) United States $0.109B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.108B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.108B 0.00
Seer (SEER) United States $0.105B 0.00
Cardiff Oncology (CRDF) United States $0.104B 0.00
Polaryx Therapeutics (PLYX) United States $0.102B 0.00
Oncolytics Biotech (ONCY) United States $0.099B 0.00
MediciNova (MNOV) United States $0.099B 0.00
Cognition Therapeutics (CGTX) United States $0.098B 0.00
Chrome Holding (MEHCQ) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.096B 0.00
Atara Biotherapeutics (ATRA) United States $0.095B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.094B 0.00
Rallybio (RLYB) United States $0.091B 0.00
Fortress Biotech (FBIO) United States $0.083B 0.94
Adicet Bio (ACET) United States $0.080B 0.00
Citius Oncology (CTOR) United States $0.080B 0.00
RenovoRx (RNXT) United States $0.078B 0.00
IBio (IBIO) United States $0.077B 0.00
Kalaris Therapeutics (KLRS) United States $0.076B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.074B 0.00
Cingulate (CING) United States $0.074B 0.00
Connect Biopharma Holdings (CNTB) United States $0.074B 0.00
Senesco Technologies (ELOX) United States $0.074B 0.00
BioStem Technologies (BSEM) $0.072B 0.00
OKYO Pharma (OKYO) $0.070B 0.00
Pliant Therapeutics (PLRX) United States $0.069B 0.00
Tenax Therapeutics (TENX) United States $0.068B 0.00
Yarrow Bioscience (YARW) United States $0.068B 0.00
LeonaBio (LONA) United States $0.068B 0.00
XBiotech (XBIT) United States $0.067B 0.00
Alps Group (ALPS) $0.067B 1.21
Spero Therapeutics (SPRO) United States $0.066B 10.27
Zhengye Biotechnology Holding (ZYBT) China $0.065B 0.00
Boundless Bio (BOLD) United States $0.064B 0.00
Alterity Therapeutics - (ATHE) Australia $0.063B 0.00
INmune Bio (INMB) United States $0.063B 0.00
Sangamo Therapeutics (SGMOQ) United States $0.061B 0.00
EXoZymes (EXOZ) United States $0.061B 0.00
Rein Therapeutics (RNTX) United States $0.061B 0.00
Xilio Therapeutics (XLO) United States $0.059B 0.00
Dogwood Therapeutics (DWTX) United States $0.059B 0.00
MiNK Therapeutics (INKT) United States $0.058B 0.00
ImageneBio (IMA) United States $0.056B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
Apollomics (APLM) United States $0.053B 0.00
Elicio Therapeutics (ELTX) United States $0.052B 0.00
Clene (CLNN) United States $0.052B 0.00
TELA Bio (TELA) United States $0.049B 0.00
Instil Bio (TIL) United States $0.049B 0.00
Prima BioMed (IMMP) Australia $0.049B 0.00
Annovis Bio (ANVS) United States $0.048B 0.00
Werewolf Therapeutics (HOWL) United States $0.048B 0.00
Grace Therapeutics (GRCE) United States $0.047B 0.00
Galecto (GLTO) Denmark $0.047B 0.00
Seres Therapeutics (MCRB) United States $0.046B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.046B 0.00
Scilex Holding (SCLX) United States $0.042B 0.00
Sensei Biotherapeutics (SNSE) United States $0.040B 0.00
Edesa Biotech (EDSA) Canada $0.040B 0.00
ATyr Pharma (ATYR) United States $0.038B 0.00
Generation Bio (GBIO) United States $0.038B 0.00
CervoMed (CRVO) United States $0.037B 0.00
Celularity (CELU) United States $0.036B 0.00
Elutia (ELUT) United States $0.035B 0.00
BioHarvest Sciences (BHST) Canada $0.035B 0.00
Cassava Sciences (FLNA) United States $0.034B 0.00
PDS Biotechnology (PDSB) United States $0.033B 0.00
Kyntra Bio Inc (KYNB) United States $0.031B 0.00
Aligos Therapeutics (ALGS) United States $0.031B 0.00
BRIACELL THERAP (BCTX) Canada $0.031B 0.00
BeyondSpring (BYSI) United States $0.031B 0.00
Gossamer Bio (GOSS) United States $0.030B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.030B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.030B 0.00
Quince Therapeutics (QNCX) United States $0.029B 0.00
ABVC BioPharma (ABVC) United States $0.029B 0.00
Athira Pharma (ATHA) United States $0.027B 0.00
IO Biotech (IOBT) Denmark $0.027B 0.00
Estrella Immunopharma (ESLA) United States $0.027B 0.00
Polyrizon (PLRZ) Israel $0.024B 0.00
BGM Group (BGM) China $0.024B 0.00
Atossa Therapeutics (ATOS) United States $0.024B 0.00
Actuate Therapeutics (ACTU) United States $0.024B 0.00
Tvardi Therapeutics (TVRD) United States $0.023B 0.00
NextCure (NXTC) United States $0.023B 0.00
Quantum Biopharma (QNTM) Canada $0.022B 0.00
Radiopharm Theranostics - (RADX) Australia $0.022B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Longeveron (LGVN) United States $0.022B 0.00
TScan Therapeutics (TCRX) United States $0.022B 0.00
Lantern Pharma (LTRN) United States $0.022B 0.00
Cyclerion Therapeutics (KRSA) United States $0.021B 0.00
Femasys (FEMY) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Neuphoria Therapeutics (NEUP) United States $0.020B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.020B 0.00
Genenta Science S.p.A (GNTA) Italy $0.020B 0.00
Palatin Technologies (PTN) United States $0.019B 0.00
Quantum Cyber N.V (QUCY) United States $0.019B 0.00
NewcelX (NCEL) Switzerland $0.019B 0.00
Jasper Therapeutics (JSPR) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
Biofrontera (BFRI) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.018B 0.00
Dyadic (DYAI) United States $0.017B 0.00
Pasithea Therapeutics (KTTA) United States $0.017B 0.00
GT Biopharma (GTBP) United States $0.016B 0.00
Cerenome (CNSY) United States $0.016B 0.00
Cyclerion Therapeutics (CYCN) United States $0.016B 0.00
Passage Bio (PASG) United States $0.015B 0.00
Moleculin Biotech (MBRX) United States $0.015B 0.00
Pluri (PLUR) Israel $0.014B 0.00
Dare Bioscience (DARE) United States $0.014B 0.00
Applied Therapeutics (APLT) United States $0.014B 0.00
Psyence Biomedical (PBM) Canada $0.014B 0.00
Lisata Therapeutics (LSTA) United States $0.014B 0.00
CalciMedica (CALC) United States $0.014B 0.00
Advanced Biomed (ADVB) United States $0.013B 1.61
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
Adial Pharmaceuticals (ADIL) United States $0.013B 0.00
Intensity Therapeutics (INTS) United States $0.012B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.012B 0.00
VistaGen Therapeutics (VTGN) United States $0.010B 0.00
IN8bio (INAB) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
KALA BIO (KALA) United States $0.010B 0.00
Medicus Pharma (MDCX) United States $0.010B 0.00
FibroBiologics (FBLG) United States $0.010B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Skye Bioscience (SKYE) United States $0.009B 0.00
Senti Biosciences (SNTI) United States $0.009B 0.00
Ensysce Biosciences (ENSC) United States $0.009B 0.00
Alzamend Neuro (ALZN) United States $0.009B 0.00
Exicure (XCUR) United States $0.009B 0.00
Hoth Therapeutics (HOTH) United States $0.008B 0.00
CNS Pharmaceuticals (CNSP) United States $0.008B 0.00
MetaVia (MTVA) United States $0.008B 0.00
Imunon (IMNN) United States $0.008B 0.00
Bolt Biotherapeutics (BOLT) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Gelteq (GELS) Australia $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
AquaBounty Technologies (AQB) United States $0.006B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Lexaria Bioscience (LEXX) Canada $0.005B 0.00
Pulmatrix (PULM) United States $0.005B 0.00
Lakewood-Amedex Biotherapeutics (LABT) United States $0.005B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.005B 0.00
Evogene (EVGN) Israel $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Black Titan (BTTC) United States $0.004B 0.00
BioAffinity Technologies (BIAF) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
HCW Biologics (HCWB) United States $0.004B 0.00
Cadrenal Therapeutics (CVKD) United States $0.004B 0.00
Biorestorative Therapies (BRTX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Beyond Air (XAIR) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
GENPREX (GNPX) United States $0.003B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.003B 0.00
Curis (CRIS) United States $0.002B 0.00
BioXcel Therapeutics (BTAI) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Abpro Holdings (ABP) United States $0.002B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.002B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.002B 0.00
Valion Bio (VBIO) United States $0.002B 0.00
Decoy Therapeutics Inc (DCOY) United States $0.002B 0.00
Purple Biotech (PPBT) Israel $0.002B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Arcadia Biosciences (RKDA) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Clinuvel Pharmaceuticals - (CUVL) Australia $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00